Regeneron Pharmaceuticals, Inc. Expands Commercial and Clinical Capabilities Through New Hires and Promotions

TARRYTOWN, N.Y.--(BUSINESS WIRE)--Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) announced today additions to their senior management group in commercial and clinical operations, as well as other staff promotions within the Company. Robert J. Terifay was named Senior Vice President, Commercial, reporting to Leonard Schleifer, M.D., Ph.D, Regeneron’s President and Chief Executive Officer. Alain Thibault, M.D., is Vice President, Clinical Sciences-Oncology, reporting to Peter Powchik, M.D., Senior Vice President of Clinical Development.